
Reset all filters
01 4Gowling Lafleur Henderson LLP
Reset all filters
01 22153856
02 22344057
Reset all filters
01 4Duloxetine Hydrochloride
Reset all filters
01 4Delayed-Release Capsule
Reset all filters
01 22015-07-13
02 22019-09-10
Patent Expiration Date : 2015-07-13
Date Granted : 2005-05-10
Brand Name : CYMBALTA
Patent Number : 2153856
Filing Date : 1995-07-13
Strength per Unit : 30 mg
Dosage Form : Delayed-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-13
Date Granted : 2005-05-10
Patent Expiration Date : 2015-07-13
Date Granted : 2005-05-10
Brand Name : CYMBALTA
Patent Number : 2153856
Filing Date : 1995-07-13
Strength per Unit : 60 mg
Dosage Form : Delayed-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-13
Date Granted : 2005-05-10
Patent Expiration Date : 2019-09-10
Date Granted : 2008-11-18
Brand Name : CYMBALTA
Patent Number : 2344057
Filing Date : 1999-09-10
Strength per Unit : 30 mg
Dosage Form : Delayed-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-09-10
Date Granted : 2008-11-18
Patent Expiration Date : 2019-09-10
Date Granted : 2008-11-18
Brand Name : CYMBALTA
Patent Number : 2344057
Filing Date : 1999-09-10
Strength per Unit : 60 mg
Dosage Form : Delayed-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-09-10
Date Granted : 2008-11-18